H. Bryson, Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

M. M. Ohayon and M. H. Lader, Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom, The Journal of Clinical Psychiatry, vol.63, issue.9, pp.817-842, 2002.
DOI : 10.4088/JCP.v63n0912

P. Verger, B. Saliba, F. Rouillon, V. Kovess-masféty, P. Villani et al., Determinants of co-prescription of anxiolytics with antidepressants in general practice, Can J Psychiatry, 2007.

. Santé, Prise en charge du patient adulte se plaignant d' insomnie en médecine générale. Saint-Denis La Plaine: HAS, 2006.

H. Autorité-de-santébaumgarten, E. M. Van-rijswijk, and E. , Modalités d' arrêt des benzodiazépines et médicaments apparentés chez le patient âgé. Saint-Denis La PlaineThe practice guideline ' Anxiety disorders' (first revision) from the Dutch College of General Practitioners; a response from the perspective of general practice], 39. van Weel-. 40. [Practice guidelines--therapy of anxiety and compulsive disorders, pp.1197-1206, 2005.

H. Bryson, Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

H. Ashton, Psychotropic-drug prescribing for women, Br J Psychiatry, issue.10, pp.30-35, 1991.

M. Baumann, J. Pommier, and J. P. Deschamps, Medical prescription and consumption of psychotropic drugs: questions on the differences between men and women], Cah Sociol Demogr Med, vol.36, issue.1, pp.63-78, 1996.

J. Glass, K. L. Lanctot, N. Herrmann, B. A. Sproule, and U. E. Busto, Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits, BMJ, vol.331, issue.7526, pp.331-1169, 2005.
DOI : 10.1136/bmj.38623.768588.47

F. Bokhari, R. Mayes, and R. M. Scheffler, An analysis of the significant variation in psychostimulant use across the U.S., Pharmacoepidemiology and Drug Safety, vol.333, issue.4, pp.267-75, 2005.
DOI : 10.1002/pds.980

E. Roberts and P. Norris, Regional variation in anti-depressant dispensings in New Zealand: 1993-1997, N Z Med J, vol.114, pp.27-30, 1125.

R. E. Clark, S. J. Bartels, T. A. Mellman, and W. J. Peacock, Recent Trends in Antipsychotic Combination Therapy of Schizophrenia and Schizoaffective Disorder: Implications for State Mental Health Policy, Schizophrenia Bulletin, vol.28, issue.1, pp.75-84, 2002.
DOI : 10.1093/oxfordjournals.schbul.a006928

P. Boyer, R. Dardennes, C. Even, V. Gaillac, A. Gérard et al., Dépression et santé publique : données et réflexions, C. Depression and obesity. Biol Psychiatry, vol.54, issue.3, pp.330-337, 1999.

M. Ohayon, Epidemiological study on insomnia in the general population

M. Occhionero, Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use, Eur J Clin Pharmacol, vol.50, issue.12, pp.19-25, 1996.

A. Winthrop, 25 MG, 0.50 MG) STILNOX (10 MG)